Project
A multicenter, double-blind, placebo-controlled phase 3 study to demonstrate the efficacy and safety of ACT-293987 in patients with pulmonary arterial hypertension
Aborted · 2009 until 2013
Burger Barbara, Haider Karin, Rüdiger Jochen, Brutsche Martin
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Aborted
Start Date
2009
End Date
2013
Financing
Industry
Study Design
A multicenter, double-blind, placebo-controlled phase 3 study
Brief description/objective
The primary objective is to demonstrate the effect of ACT-293987 on time to first clinical worsening in patients with pulmonary arterial hypertension (PAH)